The secure nationwide AI-powered cloud platform streamlines care team communication and delivers patient-specific imaging insights within clinical workflows
Chicago, IL, May 24, 2023 – Therapixel today announced that it has connected to the Nuance Precision Imaging Network™. This secure nationwide cloud platform empowers collaborative care teams with streamlined communications and AI insights from diagnostic imaging within existing workflows to improve healthcare outcomes and costs.
Therapixel created MammoScreen®, a software that helps radiologists with the interpretation of screening mammograms. With MammoScreen, even experienced radiologists improve their performance, feel more confident in their decision, and find more cancers. MammoScreen is an AI-based proficiency tool working alongside radiologists. Its uniquely actionable MammoScreen Score™ allows them to quickly confirm what they suspect and detect what they may have missed. They can concentrate on the questionable cases that require further scrutiny, while reassuring women quicker otherwise. Some of the key features include performance on 2D, 3D, and the ability to incorporate prior exams into the algorithms consideration.
Leveraging the nationwide scale of the Nuance PowerScribe and Nuance PowerShare diagnostic imaging solutions, the Nuance Precision Imaging Network connects radiologists, providers, health plans, self-insured employers, life science companies, and other imaging stakeholders to broaden access to precision diagnostics and therapeutics, increase healthcare efficiency, and lower costs. It enables secure and seamless sharing of AI insights from diagnostic imaging to enhance clinical decision-making, enhance care team collaboration, and facilitate the earlier detection and treatment of diseases for improved patient outcomes.
“We are thrilled to bring MammoScreen access to many more physicians through this collaboration with Nuance. There are major opportunities within Nuance’s very wide network and their focus on workflow and reporting efficiency,” said Matthieu Leclerc-Chalvet, Chief Executive Officer of Therapixel. “The more access we can provide to physicians the likelier it is that breast cancer can be caught earlier and thus save more lives. This strategic partnership is a great way to keep advancing in the fight against breast cancer while improving the efficiency of breast cancer screening programs.”
“In the ever-evolving landscape of healthcare, strategic collaboration holds the key to unlocking extraordinary advancements,” said Roland Dias, VP of Nuance’s Precision Imaging Network. “Together with Therapixel, we are advancing patient care, harnessing the power of cutting-edge AI and deep learning to empower radiologists and revolutionize diagnostics.”
About Therapixel
Therapixel is a French company specialized in the design and commercialization of AI-powered medical imaging software with, with the goal of delivering pertinent information at the right time to healthcare professionals. Winner of the Digital Mammography DREAM Challenge in 2017, the global competition on breast cancer detection with AI, Therapixel has developed MammoScreen®, a software that helps with the interpretation of screening 2D and 3D mammograms. With MammoScreen®, even experienced radiologists can improve their performance, feel more confident in their judgement, and reassure women quicker. Find more at www.mammoscreen.com
Media Contact
Neliya Tumbeva
media@therapixel.com